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Abstract
Injury to the skin, and the subsequent release of non-coding double-stranded RNA from necrotic 
keratinocytes, has been identified as an endogenous activator of Toll-like receptor 3 (TLR3). Since 
changes in keratinocyte growth and differentiation follow injury, we hypothesized that TLR3 
might trigger some elements of the barrier repair program in keratinocytes. Double-stranded RNA 
was observed to induce TLR3-dependent increases in human keratinocyte mRNA abundance for 
ABCA12 (ATP-binding cassette, sub-family A, member 12), glucocerebrosidase, acid 
sphingomyelinase, and transglutaminase 1. Additionally, treatment with double-stranded RNA 
resulted in increases in sphingomyelin and morphologic changes including increased epidermal 
lipid staining by oil-red O and TLR3-dependent increases in lamellar bodies and keratohyalin 
granules. These observations show that double-stranded RNA can stimulate some events in 
keratinocytes that are important for skin barrier repair and maintenance.
INTRODUCTION
Rapid recovery of epidermal barrier function following injury prevents water loss and 
opportunistic infection by infiltrating microbes. Barrier repair after injury involves 
trafficking of lamellar bodies (LB) to the SC, where they secrete their contents (Menon et 
al., 1992), and activation of several other genes, including the ATP-binding cassette sub-
family A, member 12 (ABCA12), an essential lipid transporter in the epidermis responsible 
for harlequin ichthyosis (Akiyama et al., 2005) and lamellar ichthyosis type 2 (Lefévre C et 
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al., 2003), and lipid metabolism enzymes, glucocerebrosidase (GBA) (Holleran et al., 1994) 
and acid sphingomyelinase (SMPD1) (Jensen et al., 1999). Cholesterol (Menon et al., 1985), 
free fatty acid (Mao-Quiang et al., 1993; Ottey et al., 1995), and ceramide synthesis all also 
increase following skin barrier disruption (Holleran et al., 1991; Holleran et al., 1995) and 
are essential for barrier repair. The mechanisms that regulate the complex events that 
comprise barrier repair are incompletely defined, though a calcium gradient in the epidermis 
plays an important role (Lee et al., 1992; Menon et al., 1992). In the present study we 
sought to test the hypothesis that double-stranded RNA, recently discovered to be an 
endogenous product produced by epidermal injury following trauma or excess UVB 
exposure (Lai et al., 2009; Bernard et al., 2012), might serve as a trigger for expression of 
genes important to the epidermal barrier repair process.
dsRNA recognition can occur by several mechanisms including binding to Toll-like receptor 
3 (TLR3). TLR3 signaling has largely been described as a recognition and response system 
to combat viral infections (Dunleavy et al., 2010; Kawai and Akira, 2008). Patients who 
have mutations in TLR3 (Zhang et al., 2007), UNC-93B, an ER membrane protein 
important for its trafficking to the endosome, (Casrouge et al., 2006), or TIR-domain-
containing adapter-inducing interferon-β (TRIF), a key adaptor signaling molecule for TLR3 
signaling (Sancho-Shimizu et al., 2011), are more susceptible to herpes simplex virus 
encephalitis. Thus, the importance of TLR3 in sensing viruses is not disputed, though more 
recently it has been shown to have an expanded role in a number of epithelial tissues. For 
example, inflammatory cytokines are induced by RNA released during necrosis in the gut 
(Cavassani et al., 2008) or damage to the skin (Lai et al., 2009; Bernard et al., 2012). 
Additionally, recent publications have also demonstrated that TLR3 is important for wound 
healing, as Tlr3−/− mice have a slightly delayed wound healing phenotype (Lin et al., 2011), 
while Polyinosinic acid:Polycytidylic acid (Poly (I:C)), a double-stranded RNA (dsRNA) 
analog and ligand for TLR3, can promote wound healing in mice (Lin et al., 2012).
These recent findings suggest that TLR3 may have multiple functions in the skin and may 
signal the start of barrier repair processes in addition to its role in viral defense. We show 
herein that TLR3 activation increased expression of genes critical to barrier formation, 
increased the appearance of epidermal lipids, and increased LB and keratohyalin granules 
(KHG), important elements of the epithelial barrier repair response. These findings therefore 
identify TLR3 as a potential regulator of epidermal regeneration following injury.
RESULTS
Gene expression profiling of lipid metabolism and lipid transporter pathways
To identify gene expression pathways in addition to the known inflammatory response 
associated with TLR3 activation of keratinocytes, we examined the transcriptome of NHEK 
24 hours after exposure to the dsRNA Poly(I:C). In response to Poly (I:C), a total of 5542 
differentially regulated genes changed by at least 2-fold (2773 upregulated and 2769 
downregulated; SAM: triplicate; FDR < 0.01%; delta value = 1.397) (Supplemental Figure 
S1a). These genes were further analyzed using the Database for Annotation, Visualization 
and Integrated Discovery (DAVID) (Huang et al., 2009; Huang et al., 2009). This analysis 
suggested Poly(I:C) affected a number of pathways involved in lipid metabolism and 
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transport. Specifically, changes were observed in the expression of genes in 
glycosphingolipid biosynthesis, ABC transporters, sphingolipid metabolism, and other lipid 
biosynthesis/metabolism and inflammatory pathways (Figure 1a). Several specific genes 
identified by this approach are known to play a role in maintaining or forming the skin 
barrier, such as: ABCA12 (3.74-fold), GBA (2.02-fold), SMPD1 (2.04-fold), TGM1 (2.40-
fold), as well as tumor necrosis factor (TNF) (5.31-fold), interleukin 6 (IL-6) (27.31-fold), 
and TLR3 (14.58-fold). Involucrin (IVL), loricrin (LOR), keratin 1 (KRT1), keratin 14 
(KRT14) and filaggrin (FLG), markers of epidermal differentiation, were not changed 
significantly (Figure 1b). The results of the microarray showed that genes involved in 
synthesis of ceramides (UGCG, SPTLC1, SPTLC2), free fatty acids (ACACA and FASN) 
and cholesterol (FDFT1, HMCCR, and HMGSC1) were not significantly altered other than 
acetyl CoA carboxylase (ACACA) (0.33-fold).
Poly (I:C) enhances transcript abundance of genes involved in skin barrier formation
To validate the results of the gene expression profile of Poly (I:C)-treated NHEK, we 
measured a number of genes by real time PCR. mRNA of ABCA12, GBA, SMPD1, and 
TGM1 were significantly upregulated following treatment with Poly (I:C) (Figure 2a, Table 
1). As expected, traditional inflammatory markers TNF, IL-6, and TLR3 were also 
upregulated (Figure 2b, Table 1). Consistent with microarray data, this treatment did not 
induce expression of involucrin (IVL), keratin 1 (KRT1), loricrin (LOR), filaggrin (FLG), or 
keratin 14 (KRT14) (Figure 2c, Table 1). Interestingly, Poly (I:C) treatment significantly 
induced expression of mRNA for ceramide synthesis enzymes, including serine 
palmitoyltransferase (SPTLC1 and SPTLC2) and glucosylceramide synthase (UGCG) 
(Figure 1b, Table 1). Ligands for TLR2,-7, -8, and -9 did not significantly alter expression 
of these barrier repair genes (Supplemental Figure 2a and 2b). A dose-dependent increase in 
the mRNA levels of ABCA12, GBA, SMPD1, TNF, and IL-6 was observed following 
treatment with Poly (I:C), with maximal expression seen after treatment with 0.5 to 1 μg/ml 
Poly (I:C) (Figure 2d). Increases in transcript abundance for ABCA12, GBA AND SMPD1 
was not seen until 24 hours after treatment, while TNF expression increased more rapidly 
and was maximal at 1hr (Figure 2e). However, the latter effect on gene expression was not 
due to induction of these cytokines as treatment of NHEK with TNF or IL-6 had no 
significant effect on the induction of ABCA12, GBA, or SMPD1 mRNA levels (Figure 2e).
TLR3 activation is required for dsRNA-induced changes in gene expression
To determine if the increases in ABCA12, GBA, SMPD1, and TGM1 mRNA after Poly 
(I:C) treatment were dependent on TLR3 activation, we used siRNA to knockdown TLR3 in 
NHEK. When TLR3 was significantly decreased in keratinocytes, Poly (I:C) failed to induce 
a significant increase in mRNA for the barrier repair genes ABCA12, GBA, SMPD1, TGM1 
and TNF (Figure 3a). Since TLR3 signaling is dependent on proper acidification and 
maturation of endosomes (Matsushima et al., 2004), we used Bafilomycin A1 (BafA1), a 
specific inhibitor of the V-type ATPase required for acidification of endosomes and 
lysosomes, to inhibit TLR3 signaling. BafA1 blocked Poly (I:C)-induced increases in 
ABCA12, GBA, and SMPD1 mRNA as well as increases in mRNA of the inflammatory 
cytokines TNF and IL-6 (Figure 3b). Similar effects on gene expression were seen when 
TRIF, a key signaling molecule downstream of TLR3, was knocked down (Supplementary 
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Figure S4). Unlike silencing of TLR3 or TRIF, knocking down MAVS, a key signaling 
molecule for RIG-I-like receptors that recognizes cytosolic dsRNA, had no significant effect 
on Poly (I:C)-induced expression of ABCA12, GBA, SMPD1, TGM1 (Supplemental Figure 
S5). Although TLR3 activation was important for Poly (I:C)-induced increases in UGCG 
mRNA, alterations in mRNA for several lipid synthesis genes was largely independent of 
TLR3 (Figure 3c).
Activation of TLR3 alters epidermal lipid content
To determine whether increases in ABCA12, GBA, and SMPD1 transcripts were paralleled 
by changes in epidermal lipid composition, we first stained for the presence of lipid in 
NHEK grown in differentiating conditions. A large increase in oil red O-staining bodies was 
seen when NHEK were exposed to Poly (I:C) for 72 hours (Figure 4a). A significantly 
higher expression of ABCA12 and GBA was also seen upon Poly (I:C) treatment under 
these conditions (Supplemental Figure 3a and 3b). Lipids were then quantified by measuring 
the amount of oil red O dye that was retained after staining and normalizing this to total 
protein. Poly (I:C) treatment induced significant increases in lipids stained by oil red O at 
days 1, 2 and 3 (Figure 4b). Next, 3-dimensional skin constructs were exposed to Poly (I:C) 
to determine the response of stratified and differentiated keratinocytes, that model the 
epidermis but are not influenced by the presence of resident or recruited leukocytes that 
would be present in vivo. In these 3-D skin constructs, the stratum corneum (SC) of Poly 
(I:C)-treated samples stained more strongly for oil red O compared to control samples 
(Figure 4c).
To measure the response of specific lipid components produced by cultured keratinocytes, 
total lipids were isolated from NHEK after Poly (I:C) treatment and resolved using high 
performance thin layer chromatography. Sphingomyelin was significantly increased 
following Poly (I:C) treatment and this increase was blocked following siRNA silencing of 
TLR3 (Figure 4d). Glucosylceramide levels were significantly decreased after Poly (I:C) 
treatment although this change was independent of TLR3 (Figure 4e). Ceramides increased 
following Poly (I:C) treatment, though this increase was not abolished by knock-down of 
TLR3 (Figure 4f). Cholesterol levels were not significantly altered after Poly (I:C) treatment 
in either control or TLR3 knockdown keratinocytes (Figure 4g).
TLR3 activation increases the quantity of lamellar bodies and keratohyalin granules in the 
epidermis
Since we observed increases in the staining of lipids following exposure to dsRNA, we next 
sought to determine if other morphological changes in keratinocytes could be observed by 
electron microscopy. To assess this, we quantitated the number of lamellar bodies (LB) and 
keratohyalin granules (KHG) in the upper stratum granulosum in 3-D epidermal skin 
constructs. Skin constructs treated with Poly (I:C) had significantly more LB and KHG 
(Figure 5a and 5b). The observed increases in LB and KHG were dependent on TLR3, as 
skin constructs generated from TLR3-knockdown NHEK failed to exhibit significant 
increases in LB and KHG when exposed to Poly (I:C) (Figure 5c).
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DISCUSSION
TLR activation is classically considered to result in pro-inflammatory responses. In this 
study, we demonstrate that TLR3 activation of keratinocytes also leads to changes in 
expression of some genes in keratinocytes that are associated with epidermal structure. An 
increase in transcript abundance of ABCA12, GBA, SMPD1, and TGM1 occurred in a 
TLR3-dependent manner. This response was followed by increases in epidermal lipid 
accumulation as well as increases in the abundance of LB and KHG in epidermal 
equivalents. These observations are consistent with recent observations that dsRNA is 
released by damaged cells and can serve as a damage-associated molecular pattern (DAMP). 
Thus, we now show that skin epithelial cells initiate some of the events associated with 
barrier repair after recognition of dsRNA.
The protective properties of the skin barrier reside in the SC and are heavily dependent on 
the lipid-rich lamellar membranes surrounding differentiated keratinocytes (Feingold and 
Denda, 2012; Feingold, 2007; Holleran et al., 1991). Previous studies have characterized the 
barrier repair response, delineating the increase in epidermal lipid synthesis and metabolism 
in the skin (Holleran et al., 1991; Feingold, 1991; Menon et al., 1985) and secretion of LB 
following barrier disruption (Menon et al., 1992). Because our current observations show 
TLR3 activation is accompanied by increases in mRNA encoding genes involved in 
epidermal formation, accumulation of epidermal lipids, and formation of epidermal 
organelles, we provide evidence that TLR3 may be a previously unknown mechanism by 
which keratinocytes detect epidermal injury and initiate some of the steps involved in 
formation of a functional skin barrier. However, since mice lacking TLR3 appear to develop 
normally, this recognition system is not critical to normal development. Furthermore, 
although many Poly (I:C) induced changes in lipid composition and quantity were observed, 
not all of these changes were TLR3 dependent. It is important to keep in mind that we did 
not observe a global upregulation in lipid or differentiation markers. In contrast, we 
observed that dsRNA can induce TLR3-dependent changes only in specific elements 
involved in the process of repair. How these responses combine into the complete barrier 
repair program remain to be determined.
A number of receptors are known to recognize and respond to dsRNA (Yu and Levine, 
2011), making it important to determine whether TLR3 activation was required for the gene 
expression changes seen in response to dsRNA. Using both RNA silencing and 
pharmacological inhibition, we demonstrated that increases in skin barrier genes in response 
to Poly (I:C) were dependent on TLR3. Since the Poly (I:C)-induced changes in mRNA of 
these barrier genes were almost completely abrogated when TLR3 activation was silenced, 
our data suggest that TLR3 activation is required for the observed changes. These data do 
not rule out the contribution of cytoplasmic sensors of dsRNA that exist in the cell, 
including RIG-I, MDA5, PKR, and NLRP3, although the failure of MAVS knockdown to 
partially inhibit the Poly (I:C) response argues against a role for cytoplasmic RNA 
recognition. Thus, the relevance of these sensors in keratinocytes is yet to be clearly defined.
As changes in gene expression are not seen until 24 hours after Poly (I:C) treatment, it is 
possible that the change in transcription of ABCA12, GBA, SMPD1 and TGM1 is not a 
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direct downstream transcriptional event of TLR3 activation, but rather an autocrine or 
paracrine effect dependent on synthesis of intermediate genes. TNF and IL-6 are produced 
following TLR3 activation and have been shown to improve the skin barrier (Jensen et al., 
1999; Wang et al., 2004). Therefore, we also examined the direct effects of these cytokines 
on induction of the barrier genes of interest. Since no changes in gene expression of 
ABCA12, GBA, or SMPD1 were observed with TNF or IL-6 treatment of keratinocytes 
under conditions similar to those where Poly (I:C) did induce these cytokines, it is unlikely 
that these cytokines acting alone are responsible for the observed effects. Future work will 
seek to better understand the factors responsible for transcriptional regulation of ABCA12, 
GBA, SMPD1, and TGM1 by TLR3, with specific interest in determining if these genes 
represent an immediate canonical response to TLR3 or are activated in response to 
stimulation of intermediate factors that may function in an autocrine manner.
Poly (I:C) recognition by TLR3 in keratinocytes appears to be functionally relevant. 
Sphingolipids, such as ceramides and its precursors sphingomyelin and glucosylceramides, 
are essential for the formation and maintenance of the skin barrier (Holleran et al., 1991). 
Poly (I:C)-treated keratinocytes displayed a rapid appearance of lipid-containing vesicles 
and an increase in ceramides. More intense lipid staining in the stratum corneum was also 
observed in 3-D skin constructs treated with Poly (I:C). Additionally, sphingomyelin levels 
were increased by Poly (I:C) treatment in a TLR3-dependent manner. In contrast, levels of 
glucosylceramides decreased following Poly (I:C) treatment, but not in a TLR3-dependent 
manner. These observations confirmed the importance of TLR3 activation in perturbing 
epidermal lipid levels but suggest other pathways influenced by the addition of Poly(I:C) 
also contribute to the response of some lipids. It remains to be determined whether Poly 
(I:C) treatment of NHEK can stimulate de novo lipid synthesis. As our mRNA data of a 
number of lipid metabolism genes show that dsRNA can alter these transcripts, it is possible 
that the enzyme activity could also be altered, but this remains to be explored. As ORO-
positive vesicles most likely contain a mix of nonpolar lipids, we do not believe that the 
TLR3-dependent increases in sphingomyelin are being detected in those experiments, rather 
other lipid species that have yet to be identified. Future studies will hopefully elucidate 
whether de novo lipid synthesis is occurring and which additional lipid species are increased 
in a TLR3-dependent manner.
To further investigate functional changes in keratinocytes following Poly (I:C) treatment, we 
examined ultrastructural changes in keratinocytes within 3-D skin constructs. Treatment of 
keratinocytes with Poly (I:C) yielded a higher amount of both LB and KHG in the granular 
layer of the epidermis. Although LB have been found to be depleted in the granular layer 
following barrier disruption due to their rapid trafficking and secretion of barrier 
components (Menon et al., 1992), they are rapidly regenerated to aid in future barrier repair 
as well as proper differentiation and barrier formation. We speculate that TLR3 activation 
by endogenous dsRNA could be an initiation event that leads to downstream effects of 
epidermal lipid production, trafficking, and metabolism. Increases in KHG also provide 
further evidence that Poly (I:C) treatment could promote barrier formation or repair as KHG 
also contain essential barrier components of the stratum corneum including profilaggrin and 
LOR. Though we do not see increases in transcripts of FLG and LOR after Poly (I:C) 
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treatment, the increased presence of KHG provides evidence suggesting that dsRNA can 
influence barrier formation.
We believe that this work identifies a key recognition event that could trigger some elements 
of skin barrier formation during the process of repair. How this recognition event is 
propagated after TLR3 activation remains to be determined. These results however, could be 
utilized in the treatment of certain dermatological diseases such as atopic dermatitis (AD). 
For years it has been known that AD patients have significantly decreased ceramide levels in 
the stratum corneum (Melnik et al., 1988; Yamamoto et al., 1991). Although some recent 
studies have shown AD to be associated with FLG mutations (Palmer et al., 2006), a number 
of reports cite and characterize cases of AD that are independent of FLG mutations (Jasaka 
et al., 2011) and demonstrate that AD patients have abnormal ceramide profiles and lamellar 
lipid organization (Ishikawa et al., 2010; Janssens et al., 2011). From our research, it could 
be speculated that this deficiency of ceramides in the stratum corneum of AD patients could 
be treated by pharmacological activation of pathways downstream of TLR3, thus leading to 
increases in ceramides. Of course, many unwanted inflammatory side effects may result 
from TLR3 activation, so it will be important to determine specifically which pathways 
downstream of TLR3 are involved in the increase of epidermal lipids. By examining these 
downstream pathways, we may also discover more about the regulatory events involved in 
ceramide biosynthesis and metabolism that could be affected in AD patients. Future studies 
will involve identifying and characterizing these downstream pathways of TLR3 activation 
relevant to barrier repair.
MATERIALS & METHODS
Cell Culture and Stimuli
NHEK were obtained from Cascade Biologics/Invitrogen. (catalog number: C-001-5C, 
Portland, OR), and grown in serum-free EpiLife cell culture media (Cascade Biologics/
Invitrogen) containing 0.06 mM Ca2+ and 1 × EpiLife Defined Growth Supplement (EDGS, 
Cascade Biologics/Invitrogen) at 37 °C under standard tissue culture conditions. All cultures 
were maintained for up to eight passages in this media with the addition of 100 U ml−1 
penicillin, 100 μg ml−1 streptomycin, and 250 ng ml−1 amphotericin B. Cells at 60–80% 
confluence were treated with Bafilomycin A1 (5 nM; Sigma), poly(I:C) (1 μg ml−1; 
Invivogen), IL-6 (10 ng ml − 1; R&D Systems), or tumor necrosis factor-α (50 ng ml−1; 
Chemicon, Temecula, CA) in 12-well flat bottom plates (Corning Incorporated Life 
Sciences, Lowell, MA) for up to 24 hours. After cell stimulation, RNA was extracted using 
TRIzol reagent (Invitrogen, Carlsbad, CA). RNA was stored at −80°C.
For visualization or analysis of lipids, cells were switched to advanced stage differentiation 
media (DMEM:F-12 (2:1), 10% FBS(Invitrogen),400 ng ml−1 hydrocortisone (Sigma), 10 
ug ml−1 human recombinant insulin (Sigma), and freshly made 50 ug ml−1 ascorbic acid 
(Sigma)) for 24 to 72 hours during stimulation. Media was changed every other day and 
freshly prepared and filter sterilized Vitamin C was added.
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Quantitative real-time PCR
Total RNA was extracted from cultured keratinocytes using TRIzol® Reagent (Invitrogen, 
Carlsbad, CA) and 1 ug RNA was reverse-transcribed using iScript™ cDNA Synthesis Kit 
(Bio-Rad, Hercules, CA). Pre-developed Taqman® Gene Expression Assays (Applied 
Biosystems, Foster City, CA) were used to evaluate mRNA transcript levels of ABCA12, 
GBA, SMPD1, TGM1, TNF, IL6, KRT1, KRT14, IVL, FLG, LOR, and TLR3. GAPDH 
mRNA transcript levels were evaluated using a VIC-CATCCATGACAACTTTGGTA-
MGB probe with primers 5′ CTTAGCACCCCTGGCCAAG-3′ and 5′-
TGGTCATGAGTCCTTCCACG-3′. All analyses were performed in triplicate and 
representative of three to five independent cell stimulation experiments that were analyzed 
in an ABI Prism 7000 Sequence Detection System. Fold induction relative to GAPDH was 
calculated using the ΔΔCt method. Results were considered to be significant if P < 0.05.
Supplementary Material
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ABCA12 ATP-binding cassette, sub-family A, member 12
AD atopic dermatitis
dsRNA double-stranded RNA
FLG filaggrin
GBA glucocerebrosidase
IL-6 interleukin 6
IVL involucrin
KHG keratohyalin granules
LB lamellar bodies
LOR loricrin
NHEK Normal human epidermal keratinocytes
Poly (I:C) Polyinosinic acid: polycytidylic acid
SC stratum corneum
SMPD1 acid sphingomyelinase
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TGM1 transglutaminase 1
TLR3 Toll-like receptor 3
TNF Tumor necrosis factor
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Figure 1. Gene expression profiling of NHEK identifies upregulation of genes involved in lipid 
biosynthesis, metabolism, and transporter pathways following treatment with dsRNA
(a) Significantly changed genes analyzed using DAVID to identify significant pathways 
(EASE = 1.0). (b) Genes involved in barrier formation with a significant change as 
identified by SAM
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Figure 2. Poly (I:C) enhances transcript abundance of genes involved in skin barrier formation
NHEK were cultured in the presence of 1 μg/ml Poly (I:C) for 24 h. Real-time PCR was 
used to quantify mRNA levels and fold change values are calculated relative and normalized 
to GAPDH expression for a number of (a) barrier genes, (b) inflammatory cytokines, and (c) 
keratinocyte differentiation markers. (d) NHEK were cultured with various doses of Poly 
(I:C) for 24 h. (e) NHEK were incubated with 1 μg/ml Poly (I:C), 50 ng/ml TNF, or 10 
ng/ml IL-6 for 0, 1, 3, 6, or 24. h. Data are mean ± SEM, n = 3, and are representative of at 
least three independent experiments. *P < 0.05. Two tailed T-test.
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Figure 3. TLR3 activation is required for dsRNA-induced changes in gene expression
(a) TLR3 was silenced in NHEK for 48 h before treatment with 1 μg/ml Poly (I:C) for 24 h. 
Real-time PCR was used to quantify mRNA levels and fold change values are calculated 
relative and normalized to GAPDH expression. *P < 0.05. Two tailed T-test. (b) NHEK 
were treated with 5 nM Bafilomycin A1 for 1 h prior to treatment with 1 μg/ml Poly (I:C) 
for 24 h. ***P < 0.001. One-way ANOVA. (c) TLR3 was silenced in NHEK for 48 h before 
treatment with 1 μg/ml Poly (I:C) for 24 h. Real-time PCR was used to quantify mRNA 
levels and fold change values are calculated relative to and normalized to GAPDH 
expression. *P < 0.05. Two tailed T-test. Data are mean ±SEM, n = 3, and are representative 
of at least three independent experiments.
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Figure 4. Activation of TLR3 alters epidermal lipid content
(a) NHEK were treated for 72 h with 10 μg/ml Poly (I:C), stained with Oil Red O and 
counterstained with Hematoxylin. Scale bar = 50 μm. (b) NHEK were treated with 1 μg/ml 
Poly (I:C) for 1, 2, or 3 days, then stained with Oil Red O. (c) 3-D tissue constructs were 
treated with 1 μg/ml Poly (I:C) for 72 h. Samples were stained with Oil Red O and 
counterstained with Hematoxylin. Scale bar = 50 μm. (d–g) NHEK were treated with 1 
μg/ml Poly (I:C) for 24 h following siRNA knockdown of TLR3. (d) Sphingomyelin, (e) 
glucosylceramide (f) ceramides, and (g) cholesterol were quantified using HPTLC relative 
to total protein. *P < 0.05. Two-tailed T-test. Data are mean ±SEM, n =3, and are 
representative of at least three independent experiments.
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Figure 5. TLR3 activation increases the quantity of LB and KHG in the epidermis
(a) Transmission electron microscopy of 3-D skin construct treated with 1 μg/ml Poly IC for 
72 h. Arrow = LB. Arrowhead= KHG. Scale bar = 1 μm. SC = stratum corneum. SG = 
stratum granulosum. (b) Quantification of LB and KHG. *P < 0.05; One-tailed T-test. 
Control (n = 54), 1 μg/ml Poly (I:C) (n = 47). Data are mean ± SEM. (c) Quantification of 
LB and KHG in TLR3 knockdown NHEK. *P < 0.05, **P < 0.01, ***P < 0.001. One tailed 
T-Test. Control siRNA Control (n=54), Control siRNA + 1 μg/ml Poly (I:C) (n = 51), TLR3 
siRNA Control (n = 55), TLR3 siRNA + 1 μg/ml Poly (I:C) (n = 54). Data are mean ± SEM.
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